CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Recruiting now
Conditions studied: Multiple Myeloma, Multiple Myeloma Progression, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), Plasma Cell Disorders
In brief
The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.
Key facts
- Study ID
- NCT06644625
- Run by
- Wake Forest University Health Sciences
- People needed
- 1665
- Starts
- 2025-03-01
- Expected to finish
- 2035-01-01
- Last updated by the study team
- 2026-07-13
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Atrium Health Levine Cancer — Charlotte, North Carolina, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.